CoChat

Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial

Open access

The DOI matches its Crossref record; 53 of the 59 references it cites were found in a registry or an index.

Abstract

Background Hypnotherapy for irritable bowel syndrome (IBS) has been used primarily in patients with refractory symptoms in specialised departments and delivered on an individual basis. We aimed to test the hypothesis that hypnotherapy would be more effective than educational supportive therapy, and that group hypnotherapy would be non-inferior to individual hypnotherapy for patients with IBS referred from primary and secondary care. Methods We did a multicentre randomised controlled trial (IMAGINE) in 11 hospitals in the Netherlands. Patients with IBS, aged 18-65 years, who were referred from primary or secondary care were randomly allocated (3:3:1) in blocks of six using a computer-based random number table procedure by staff not involved in the treatment to receive six sessions of individual or group hypnotherapy or group educational supportive therapy (control group). The primary outcome was adequate relief of IBS symptoms, with responders defined as patients who reported adequate relief when asked once weekly on three or four occasions in 4 consecutive weeks. We compared hypnotherapy (both groups) with control in the intention-to-treat population (excluding individuals subsequently found to be ineligible for enrolment), and assessed non-inferiority of group hypnotherapy versus individual hypnotherapy in the per-protocol population (with a non-inferiority margin of 15%) at 3 months and 12 months. This trial is registered with ISRCTN, number ISRCTN22888906, and is completed. Findings Between May 31, 2011, and April 6, 2016, 494 patients referred for psychological treatment for IBS were assessed for eligibility, of whom 354 were randomly allocated to the three groups: 150 to individual hypnotherapy, 150 to group hypnotherapy, and 54 to educational supportive therapy. After exclusion of individuals subsequently found to be ineligible for enrolment, 142 patients in the individual hypnotherapy group, 146 in the group hypnotherapy group, and 54 in the control group were included in the intention-to-treat population. Of these, 22 (15%) patients in the individual hypnotherapy group, 22 (15%) in the group hypnotherapy group, and 11 (20%) in the control group dropped out before or during therapy. In the intention-to-treat analysis, the adequate response rate was 40·8% (95% CI 31·7-50·5) in the individual hypnotherapy group, 33·2% (24·3-43·5) in the group hypnotherapy group, and 16·7% (7·6-32·6) in the control group at 3 months. At 12 months, 40·8% (31·3-51·1) of patients in the individual hypnotherapy group, 49·5% (38·8-60·0) of patients in the group hypnotherapy group, and 22.6% (11·5-39·5) of patients in the control group reported adequate relief. Hypnotherapy was more effective than control at 3 months (odds ratio 2·9, 95% CI 1·2-7·4, p=0·0240) and 12 months (2·8, 1·2-6·7, p=0·0185). In the per-protocol analysis, 49·9% (39·2-60·6) in the individual hypnotherapy group and 42·7% (32·3-53·8) in the group hypnotherapy group had adequate relief at 3 months, and 55·5% (43·4-67·1) of individual and 51·7% (40·2-63·0) of group hypnotherapy patients reported adequate relief at 12 months. Group hypnotherapy was therefore non-inferior to individual hypnotherapy. Eight unexpected serious adverse reactions (six in the individual hypnotherapy group and two in the group hypnotherapy group) were reported, most of which were cancer or inflammatory bowel disease, and were judged by the medical ethics committee as not being related to the therapy. Interpretation Hypnotherapy should be considered as a possible treatment for patients with IBS in primary and secondary care. Furthermore, group therapy could allow many more patients to be treated for the same cost. Funding None.

Overview

CoChat Summary

TL;DR

In a multicentre randomised controlled trial in 11 Dutch hospitals, hypnotherapy (individual or group) produced higher rates of adequate relief of IBS symptoms than group educational supportive therapy at both 3 and 12 months. Group hypnotherapy was non-inferior to individual hypnotherapy, suggesting group delivery could treat more patients for the same cost.

Key findings

  • In the intention-to-treat analysis, adequate response rates at 3 months were 40·8% (95% CI 31·7–50·5) for individual hypnotherapy, 33·2% (24·3–43·5) for group hypnotherapy, and 16·7% (7·6–32·6) for control; at 12 months they were 40·8% (31·3–51·1), 49·5% (38·8–60·0), and 22·6% (11·5–39·5), respectively.
  • Hypnotherapy was more effective than control at 3 months (odds ratio 2·9, 95% CI 1·2–7·4, p=0·0240) and at 12 months (2·8, 1·2–6·7, p=0·0185).
  • In the per-protocol analysis, group hypnotherapy was non-inferior to individual hypnotherapy (15% margin): 49·9% (39·2–60·6) vs 42·7% (32·3–53·8) at 3 months, and 55·5% (43·4–67·1) vs 51·7% (40·2–63·0) at 12 months.
  • Eight unexpected serious adverse reactions were reported (six in individual hypnotherapy, two in group hypnotherapy), most being cancer or inflammatory bowel disease, judged by the medical ethics committee as not related to therapy.

Methods

  • Multicentre randomised controlled trial (IMAGINE) in 11 hospitals in the Netherlands; patients with IBS aged 18–65 years referred from primary or secondary care were randomly allocated (3:3:1) in blocks of six to six sessions of individual hypnotherapy, group hypnotherapy, or group educational supportive therapy (control).
  • 494 patients were assessed for eligibility (May 31, 2011–April 6, 2016) and 354 were randomised (150 individual, 150 group, 54 control); after excluding subsequently ineligible individuals, the intention-to-treat population comprised 142, 146, and 54 patients, respectively.
  • Primary outcome was adequate relief of IBS symptoms, with responders defined as reporting adequate relief when asked once weekly on three or four occasions in 4 consecutive weeks; hypnotherapy (both groups) was compared with control in the intention-to-treat population, and non-inferiority of group versus individual hypnotherapy was assessed per-protocol at 3 and 12 months.

Limitations

  • The provided text does not state limitations explicitly ("Not stated in the paper" for author-stated limitations).
  • Evident from the text: dropout before or during therapy was 22 (15%) in individual hypnotherapy, 22 (15%) in group hypnotherapy, and 11 (20%) in the control group, and the control arm was substantially smaller (n=54) than the hypnotherapy arms.
  • Evident from the text: the non-inferiority conclusion rests on the per-protocol population rather than the intention-to-treat population.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(18)30310-8

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 0 Not checked · 12 Own results and interpretations

  • It may state two separate claims as one. 5
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

1 of 1

Citations

Cites

Show all 53 references

Cited by

See all 126

Metadata

Authors
Flik, C. E., Laan, W., Zuithoff, N. P. A., van Rood, Y. R., Smout, A. J. P. M., Weusten, B. L. A. M., Whorwell, P. J., & de Wit, N. J.
Affiliations
  • University Medical Center Utrecht (NL)
  • Leiden University Medical Center (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Wythenshawe Hospital (GB)
Corresponding author
Flik, Carla E
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2019-01
Volume
4
Issue
1
Pages
20-31
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W2901140679
Cited by
126
References
59
Citations by year
2026: 9 · 2025: 16 · 2024: 17 · 2023: 17 · 2022: 15 · 2021: 17 · 2020: 20 · 2019: 14
FWCI
10.27
Type
journal article
Language
en
Licence
  • other-oa
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet. Gastroenterology & hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
Keywords
irritable bowel syndrome, hypnotherapy, symptom relief, non-inferiority, psychological intervention, treatment response rate, adverse events, patient satisfaction, patient-reported outcomes, quality of life, health-related quality of life, health care costs, health care utilization
MeSH terms
Equivalence Trials as Topic, Adult, Female, Humans, Hypnosis, Male, Middle Aged, Patient Education as Topic, Psychotherapy, Group, Irritable Bowel Syndrome, Intention to Treat Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. https://app.cochat.ai/papers/10.1016/s2468-1253(18)30310-8
The paper
Flik, C. E., Laan, W., Zuithoff, N. P. A., van Rood, Y. R., Smout, A. J. P. M., Weusten, B. L. A. M., Whorwell, P. J., & de Wit, N. J. (2019). Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(18)30310-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.